Amyotrophic Lateral Sclerosis Treatment Market Affects 30,000 People in the United States, With 5,000 New Cases Diagnosed Each Year
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder. It affects the nerve cells in the central nervous system that controls the voluntary muscles. Muscle twitching, weakness, and stiff muscles are some of the symptoms of the amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis is also known as Lou Gehrig's disease. The rising prevalence of amyotrophic lateral sclerosis is a prime factor driving growth of the amyotrophic lateral sclerosis treatment market. According to The Johns Hopkins University, it affects as many as 30,000 in the United States, with 5,000 new cases diagnosed each year. Estimates suggest that ALS is responsible for as many as five of every 100,000 deaths in people aged 20 or older. The growing geriatric population is increasing the prevalence of amyotrophic lateral sclerosis which is again propelling the growth of the amyotrophic lateral sclerosis treatment market . According to the United Nation, in 2019, there were 703 million